BrainsGate completes $14 million financing round led by a new investor

Originally published at: https://www.jbklutse.com/brainsgate-completes-14-million-financing-round/

BrainsGate, a developer of a novel proprietary treatment for Ischemic stroke (Ischemic Stroke System), has secured $14 million in a new investment round at a pre-money valuation of $147 million. New investor, BNP Joint Capital Fund, and the Impact investment and consulting firm SPERO led the round alongside existing investors, Elron, Medtronic, Agate, Pitango, and…